Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment.

Chen S, Kawashima H, Lowe JB, Lanier LL, Fukuda M.

J Exp Med. 2005 Dec 19;202(12):1679-89. Epub 2005 Dec 13.

2.

The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands.

Elsner L, Muppala V, Gehrmann M, Lozano J, Malzahn D, Bickeböller H, Brunner E, Zientkowska M, Herrmann T, Walter L, Alves F, Multhoff G, Dressel R.

J Immunol. 2007 Oct 15;179(8):5523-33.

3.

Role of natural killer cells in control of cancer metastasis.

Hanna N.

Cancer Metastasis Rev. 1982;1(1):45-64.

PMID:
7185419
4.

In vivo natural killer cell activities revealed by natural killer cell-deficient mice.

Kim S, Iizuka K, Aguila HL, Weissman IL, Yokoyama WM.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2731-6.

5.

Role of natural killer cells in the destruction of circulating tumor emboli.

Hanna N, Fidler IJ.

J Natl Cancer Inst. 1980 Oct;65(4):801-9.

PMID:
6932529
6.

NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain.

Prins RM, Vo DD, Khan-Farooqi H, Yang MY, Soto H, Economou JS, Liau LM, Ribas A.

J Immunol. 2006 Dec 15;177(12):8448-55.

7.

Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice.

Stremmel C, Sienel W, Eggeling S, Passlick B, Slavin A.

Eur J Cardiothorac Surg. 2006 Aug;30(2):362-9. Epub 2006 Jul 7.

PMID:
16828564
8.

DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases.

Chan CJ, Andrews DM, McLaughlin NM, Yagita H, Gilfillan S, Colonna M, Smyth MJ.

J Immunol. 2010 Jan 15;184(2):902-11. doi: 10.4049/jimmunol.0903225. Epub 2009 Dec 11.

9.
10.

Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line.

Yokoyama H, Nakanishi H, Kodera Y, Ikehara Y, Ohashi N, Ito Y, Koike M, Fujiwara M, Tatematsu M, Nakao A.

Clin Cancer Res. 2006 Jan 15;12(2):361-8.

11.

Qa-1(b)-dependent modulation of dendritic cell and NK cell cross-talk in vivo.

Colmenero P, Zhang AL, Qian T, Lu L, Cantor H, Söderström K, Engleman EG.

J Immunol. 2007 Oct 1;179(7):4608-15.

12.

Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx.

Wustrow TP, Zenner HP.

Laryngoscope. 1985 Nov;95(11):1391-400. Review.

PMID:
3903404
13.

Expression of L-selectin ligands by transformed endothelial cells enhances T cell-mediated rejection.

Biancone L, Stamenkovic I, Cantaluppi V, Boccellino M, De Martino A, Bussolino F, Camussi G.

J Immunol. 1999 May 1;162(9):5263-9.

14.

Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells.

Laffont S, Seillet C, Ortaldo J, Coudert JD, Guéry JC.

Blood. 2008 Aug 1;112(3):661-71. doi: 10.1182/blood-2007-10-120089. Epub 2008 May 27.

15.

NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis.

Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, Young HA, Wynn TA, Sher A.

J Immunol. 2006 Nov 15;177(10):7086-93.

16.

Murine lymph node natural killer cells: regulatory mechanisms of activation or suppression.

Hisano G, Hanna N.

J Natl Cancer Inst. 1982 Sep;69(3):665-71.

PMID:
6180211
17.

IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma.

Jiang Q, Wei H, Tian Z.

J Immunother. 2008 Jul-Aug;31(6):555-62. doi: 10.1097/CJI.0b013e31817d8e75.

PMID:
18528299
18.

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.

Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y.

J Immunol. 2006 Feb 1;176(3):1582-7.

19.

Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines.

Winter H, van den Engel NK, Rüttinger D, Schmidt J, Schiller M, Poehlein CH, Löhe F, Fox BA, Jauch KW, Hatz RA, Hu HM.

J Transl Med. 2007 Nov 14;5:56.

20.

Cell type-specific roles of carbohydrates in tumor metastasis.

Chen S, Fukuda M.

Methods Enzymol. 2006;416:371-80.

PMID:
17113879

Supplemental Content

Support Center